InvestorsHub Logo
Boards
News
Market Data
Markets
Discover
Discover
Subscribe Login/Register
S&P 500
5,216.77
(
0.05%
)
US TECH 100
17,685.00
(
0.25%
)
Dow Jones
39,460.69
(
0.19%
)
Brent Oil
82.72
(
-1.47%
)
Bitcoin
60,506.80
(
-4.02%
)
Post# of 251786
Next 10
Reply Private New
Public Reply Private Reply New Post
Keep Last Read
Keep Next 10 Report Keyboard Shortcuts
Next 10 Prev Next

BiotechValues

Send PM Follow Ignore
Followers 355
Posts 9910
Boards Moderated 2
Alias Born 06/23/2007

BiotechValues

Re: None

Tuesday, 09/20/2016 10:27:44 AM

Tuesday, September 20, 2016 10:27:44 AM

Post# of 251786
TapImmune (TPIVD) uplisting to NASDAQ with FOUR Phase II trials in ovarian and breast cancer underway or starting.


8.3 million shares, market cap $48 million, partnership with AZN, Mayo Clinic, MSKCC, and fast track FDA status for ovarian cancer drug.

Trading thin now- but I believe that will change as uplisting happens in next week or two.


IRP Disclosure

Public Reply Private Reply New Post
Keep Last Read
Keep Last Read Next 10 Report Keyboard Shortcuts
Next 10 Prev Next

Join the InvestorsHub Community

Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.

Sign Up